Author： Temesgen Zelalem
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.8, 2001-08, pp. : 1239-1246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The availability of potent antiretroviral drugs and their use in combination regimens has led to a dramatic decline in the morbidity and mortality associated with HIV infection. Currently, there are 15 FDA-approved antiretrovirals categorised into three classes of drugs. Several others are in various stages of basic and clinical development.
Related content
Current status of antiretroviral therapy
By Temesgen Zelalem Warnke David Kasten Mary J
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
Access to resources
Recommend
Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. :
Disease-Modifying Therapies for Osteoarthritis: Current Status
By Marc Fajardo Paul E. Di Cesare
Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. :
Targeted Therapies for Gastric Cancer: Current Status
By Yoong Jaclyn
Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. :
Current Status of Targeted Therapies for Mantle Cell Lymphoma
By Chang Julie E. Kahl Brad S.
Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. :